Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
Gautam Prasad(University of California, San Francisco), Daphne A. Haas‐Kogan(Neurology, Inc)
Cited by 158
Related Papers
A druggable addiction to <i>de novo</i> pyrimidine biosynthesis in diffuse midline glioma
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0